黛矾散干预Th17/Treg平衡防治原发性胆汁性胆管炎的作用机制

占凯; 徐燕; 韩梦玲; 程良斌

doi:10.3969/j.issn.1001-5256.2018.11.021

黛矾散干预Th17/Treg平衡防治原发性胆汁性胆管炎的作用机制

DOI: 10.3969/j.issn.1001-5256.2018.11.021

1. 襄阳市中医院肝胆病科
2. 武汉万济精神病医院精神科
3. 广东省中医院大学城医院肝病科
4. 湖北省中医院肝病研究所

基金项目:

湖北省教育厅重点项目(D20112001)；武汉市科技局基金项目(武科技[2015]203号2015061701011646)；

详细信息

中图分类号: R575.7
计量
- 文章访问数: 1838
- HTML全文浏览量: 59
- PDF下载量: 357
- 被引次数: 0
出版历程
- 出版日期: 2018-11-20

Mechanism of action of Daifan powder in the prevention and treatment of primary biliary cholangitis via its interventional effect on Th17/Treg balance

Research funding:

摘要

摘要:
目的观察不同剂量的黛矾散对聚肌胞苷酸（Poly I∶C）诱导的原发性胆汁性胆管炎（PBC）模型小鼠外周血辅助性T淋巴细胞17（Th17）、CD4+CD25+Foxp3+调节性T淋巴细胞（Treg）及Th17/Treg比值的影响,进一步探讨黛矾散治疗PBC的作用机制。方法将90只C57BL/6雌性小鼠随机分成正常组、模型组、黛矾散低剂量组、黛矾散中剂量组、黛矾散高剂量组、熊去氧胆酸（UDCA）组,用Poly I:C诱导PBC模型,观察黛矾散对PBC模型小鼠血清学的影响。检测外周血中肝功能相关指标,采用流式细胞技术检测外周血Treg、Th17比例,HE染色检测肝组织病理结构。符合正态分布的计量资料2组间比较采用t检验,多组间比较采用单因素方差分析,进一步两两比较采用LSD-t检验;非正态分布的计量资料2组间比较采用两独立样本Mann-Whitney U非参数检验,多组间比较采用多独立样本Kraskal-Wallis H非参数检验,相关分析采用Spearman相关性检验。结果与正常组比较,模型组和UDCA组血清ALT、AST、...
- 黛矾散 /
- 肝硬化,胆汁性 /
- T淋巴细胞,辅助诱导 /
- T淋巴细胞,调节性
Abstract:
Objective To investigate the effect of different doses of Daifan powder on peripheral blood T helper 17 ( Th17) cells, CD4+CD25+Foxp3+regulatory T ( Treg) cells, and Th17/Treg ratio in a mouse model of primary biliary cholangitis ( PBC) induced by polyinosinic-polycytidylic acid ( Poly I∶ C) and the mechanism of action of Daifan powder in the treatment of PBC. Methods A total of 90 C57 BL/6 female mice were randomly divided into normal group, model group, low-, middle-, and high-dose Daifan powder groups, and ursodeoxycholic acid ( UDCA) group. Poly I: C was used to establish a model of PBC, and the effect of Daifan powder on the serology of PBC mice was observed. Liver function parameters were measured; flow cytometry was used to measure the percentages of peripheral blood Treg cells and Th17 cells; HE staining was used to observe liver pathology. The t-test was used for comparison of normally distributed continuous data between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. The Mann-Whitney U test ( for two independent samples) was used for comparison of non-normally distributed continuous data between two groups; the Kruskal-Wallis H test ( for two or more independent samples) was used for comparison between multiple groups. Spearman correlation was used for the correlation analysis. Results Compared with the normal group, the model group and the UDCA group had significant increases in the serum levels of alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) , alkaline phosphatase ( ALP) , total bilirubin ( TBil) , and direct bilirubin ( DBil) ( all P <0. 05) . Compared with the model group, the low-, middle-, and high-dose Daifan powder groups had significant reductions in the serum levels of ALT, AST, ALP, TBil, and DBil ( all P < 0. 05) . In the model group, peripheral blood Th17/Treg ratio was not correlated with ALT, AST, ALP, TBil, and DBil ( all P < 0. 05) . Compared with the normal group, the model group had a significant increase in the percentage of peripheral blood Th17 cells ( P < 0. 01) ; compared with the model group, the low-, middle-, and high-dose Daifan powder groups had a significant reduction in the percentage of peripheral blood Th17 cells ( all P < 0. 01) . Compared with the normal group, the model group had a significant reduction in the percentage of peripheral blood Treg cells ( P < 0. 01) ; compared with the model group, the low-, middle-, and high-dose Daifan powder groups had a significant increase in the percentage of peripheral blood Treg cells ( all P <0. 01) . Compared with the normal group, the model group had a significant increase in peripheral blood Th17/Treg ratio ( P < 0. 01) ; compared with the model group, the low-, middle-, and high-dose Daifan powder groups had a significant reduction in peripheral blood Th17/Treg ratio ( all P < 0. 01) . Conclusion Daifan powder exerts a therapeutic effect on PBC by breaking Th17/Treg balance and reducing immune inflammatory reaction.
- Daifansan /
- liver cirrhosis, biliary /
- T-lymphocytes, helper-inducer /
- T-lymphocytes, regulatory

HTML全文

参考文献(22)

[1] Working Subgroup (English version) For Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis:The intractable hepatobiliary disease study group supported by the Ministry of Health, Labour and Welfare of Japan[J]. Hepatology Research, 2014, 44 (Suppl 1) :71-90.

[2] MARCHIONI BEERY RM, VAZIRI H, FOROUHAR F. Primary biliary cirrhosis and primary sclerosing cholangitis:A review featuring a women's health perspective[J]. J Clin Transl Hepatol, 2014, 2 (4) :266-284.

[3] INVERNIZZI P, SELMI C, GERSHWIN ME, et al. Update on primary biliary cirrhosis[J]. Dig Liver Dis, 2010, 42:401.

[4] YANG XZ. Balance between T helper 17 cells and regulatory T cells in the pathogenesis of primary biliary cirrhosis[D]. Beijing:Peking Union Medical College, 2011. (in Chinese) 杨洵哲. Th17细胞与Treg细胞平衡在原发性胆汁性肝硬化发病机制中的意义初探[D].北京:北京协和医学院, 2011.

[5] SARKAR S, FOX DA. Targeting IL-17 and Th17 cells in rheumatoid arthritis[J]. Rheum Dis Clin North Am, 2010, 36 (2) :345-366.

[6] RONG G, ZHOU Y, XIONG Y, et al. Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis:The serum cytokine profile and peripheral cell population[J].Clin Exp Immunol, 2009, 156 (2) :217-225.

[7] CHENG LB, YU XL. Curative effect of Daifan powder on intrahepatic cholestasis[J]. Chin J Integr Tradit West Med Liver Dis, 2009, 19 (1) :10-12. (in Chinese) 程良斌, 余晓丽.黛矾散治疗肝内胆汁游积症的临床研究[J].中西医结合肝病杂志, 2009, 19 (1) :10-12.

[8] CHENG LB, ZHAO YY, WANG H, et al. The Effects of Daifansan on strogen induced intrahepatic cholestasis in rats[J]. J Clin Hepatol, 2003, 19 (6) :370-371. (in Chinese) 程良斌, 赵友云, 汪晖, 等.黛矾散对雌激素诱导的大鼠肝内胆汁淤积的影响[J].临床肝胆病杂志, 2003, 19 (6) :370-371.

[9] CHENG LB, ZHAO YY, WANG H, et al. The effects of daifansan on memberane fluidity of estrogen-induced intrahepatic cholestasis in rats[J]. J Clin Hepatol, 2004, 20 (6) :359-360. (in Chinese) 程良斌, 赵友云, 汪晖, 等.黛巩散对雌激素诱导的大鼠肝内胆汁淤积肝细胞膜流动性的影响[J].临床肝胆病杂志, 2004, 20 (6) :359-360.

[10] ZHOU JH, YAN JS, CHENG LB. The effects of Daifansan on ANIT induced in trahepatic cholestasis in rats[J]. Chin J Integr Tradit West Med Liver Dis, 2016, 26 (1) :32-33. (in Chinese) 周金辉, 严俊松, 程良斌.黛矾散对a-奈异硫氰酸脂诱导的大鼠肝内胆汁淤积的影响[J].中西医结合肝病杂志, 2016, 26 (1) :32-33.

[11] LIU P. The modern Chinese medicine liver disease[M]. Beijing:People's Medical Publishing House, 2002:243. (in Chinese) 刘平.现代中医肝脏病学[M].北京:人民卫生出版社, 2002:243.

[12] HARADA K, SHIMODA S, SATO Y, et al. Periductal interleukin-17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis[J]. Clin Exp Immunol, 2009, 157 (2) :261-270.

[13] KOPF H, de la ROSA GM, HOWARD OMZ, et al. Rapamycin inhibits differentiation of Th17 cells and promotes generation of Fox P3+T regulatory cells[J]. Int Immunopharmacol, 2007, 7:1819-1824.

[14] CHU JX, CHU YL. Indirubin the fruit of combination of Chinese traditional and Western medicine[J]. Chin J Hematol, 2017, 38 (6) :559-560. (in Chinese) 褚建新, 储榆林.靛玉红——中西医结合研究的一项硕果[J].中华血液学杂志, 2017, 38 (6) :559-560.

[15] LAI JL, LIU YH, LIU C, et al. Research progress on the mechanism and clinical application of indirubin[J]. J Tradit Chin Vet Med, 2017, 36 (1) :76-79. (in Chinese) 赖金伦, 刘玉辉, 刘畅, 等.中药靛玉红作用机理及其临床应用研究进展[J].中兽医医药杂志, 2017, 36 (1) :76-79.

[16] ZHANG Y, ZHANG M. Research on the effects of indigo on TGAb、TPOAb of experimental autoimmue thyroiditis rats[J]. Shanghai J Tradit Chin Med, 2016, 50 (9) :77-80. (in Chinese) 张毅, 张敏.青黛对实验性自身免疫甲状腺炎大鼠TGAb、TPOAb的影响[J].上海中医药杂志, 2016, 50 (9) :77-80.

[17] ZHANG AJ, QU YY, ZHANG BJ, et al. The different effects of indirubin on effector and CD4+CD25+regulatory T cells in mice:Potential implication for the treatment of autoimmune diseases[J]. J Mol Med, 2007, 85 (11) :1263-1270.

[18] KIM JK, PARK GM. Indirubin-3-monoxime exhibits anti-inflammatory properties by down-regulating NF-κB and JNK signaling pathways in lipopolysaccharide-treated RAW 264. 7 cells[J].Inflamm Res, 2012, 61 (4) :319-325.

[19] LIU LJ, WANG YL, LI JX. Study of indigo on ulcerative colitis inf lammatory cell model in vitro[J]. China J Tradit Chin Med Pharma, 2014, 29 (5) :1666-1669. (in Chinese) 刘丽娟, 王允亮, 李军祥.靛蓝对溃疡性结肠炎体外炎症模型的作用[J].中华中医药杂志, 2014, 29 (5) :1666-1669

[20] Mc KEE AS, BURCHILL MA, MUNKS MW, et al. Host DNA released in response to aluminum adjuvant enhances MHC class IImediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells[J]. Proc Natl Acad Sci U S A, 2013, 110 (12) :e1122-e1131.

[21] MCKEE AS, MACLEOD M, WHITE J, et al. Gr1+IL-4-producing innate cells are induced in response to Th2 stimuli and suppress Th1-dependent antibody responses[J]. Int Immunol, 2008, 20 (5) :659-669.

[22] MASSON JD, CRPEAUX G, AUTHIER FJ, et al. Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics[J]. Ann Pharm Fr, 2017, 75 (4) :245-256.

施引文献

资源附件(0)

访问统计